0
Bifidobacteria found to inhibit SARS-CoV-2
Researchers have discovered certain bacteria that reside in the human intestine secrete compounds that inhibit SARS-CoV-2. Research from Yonsei…
Browsing: Research > Basic
0
Gene atlas of malaria parasite reveals potential drug and vaccine targets
Scientists from Imperial College London (UK) and the Wellcome Sanger Institute (Cambridge, UK) have mapped the genetic changes malaria parasites…
0
Plankton vs parasites
New research using plankton has revealed that not all hosts are equal when it comes to infectious disease spread between…
0
New sequencing studies shed more light on the B.1.1.7 SARS-CoV-2 variant
Two new studies have shed light on the B.1.1.7 variant, suggesting that while it is more transmissible, it does not…
0
nAbbing SARS-CoV-2 variants
New SARS-CoV-2 variants mean new neutralizing antibodies to deal with them. With the COVID-19 pandemic on its third wave in some…
0
What effect will SARS-CoV-2 variants have on vaccine efficacy?
The ‘inevitable’ domination of novel SARS-CoV-2 variants from Brazil, South Africa and the UK could result in less effective COVID-19…
0
One drug to rule them all?
Thapsigargin, a promising broad-spectrum antiviral, has proven effective for use against SARS-CoV-2, as well as the influenza A and respiratory…
0
Natural immunity to COVID-19: how long and how strong?
Two recent papers from Public Health England (PHE; London, UK) and Rockefeller University (NY, USA) have shed new light on the duration and quality of protection provided…
0
A nasal spray a day could keep COVID-19 away
Hands, face, space. These are the three tools available to everyday citizens to prevent the spread of COVID-19; the simple…
0
Everything we know about the UK’s novel, emergent strain of COVID-19
As a new COVID-19 strain emerges in the southeast of England that appears to be more infectious than previous strains, what do…